Changing trends in the biopharma sector may mean new risks for established players and opportunities for growth, says BIA ...

NewCo’ licensing of clinical candidates is allowing Chinese biotechs to offload costs while expanding profits on a global ...

As CF treatment duration extends, registry-based analyses will need to track pathogen-specific trends and long-term disease ...

Johnson & Johnson's Tremfya is the first IL-23 inhibitor to gain FDA approval in a paediatric population for plaque psoriasis ...

Oral liquid drugs play a vital role for patients who have difficulty swallowing tablets and for those requiring personalised ...

MasterControl research shows 40% of advanced therapy executives aren't confident they can meet CGT demand over the next three ...

More than two-thirds – 67% - of first responders organisations have deployed new cybersecurity protections in the last 12 ...

The US FDA has expanded the approval of Regeneron Pharmaceuticals' fully human monoclonal antibody, Evkeeza (evinacumab-dgnb) ...

Amgen has revealed a significant investment plan, earmarking $650m to enhance its manufacturing operations in the US.

AstraZeneca has launched an online direct-to-consumer (DTC) medicine platform in the US, joining a growing list of companies ...

Lithuania is rapidly growing as a leading force in the European life sciences scene, with over 400 life sciences companies in ...